Priming of hippocampal microglia by IFN-γ/STAT1 pathway impairs social memory in mice.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and in vitro mechanistic laboratory study
PubMed 38759369 · doi:10.1016/j.intimp.2024.112191
What was done
Male C57BL/6J mice received intracerebroventricular injections of IFN-γ (500 ng) and were assessed for social preference and social memory using the three-chamber social test. Researchers evaluated microglial morphology and inflammatory markers in the hippocampus, prelimbic cortex, and amygdala using immunohistochemistry and ELISA, alongside an LPS challenge to test priming and sickness behavior. STAT1 signaling and microglia-neuron interactions were examined in vivo and in primary microglia cultures, with fludarabine (a STAT1 inhibitor) or minocycline administered to assess functional rescue.
What was found
Intracerebroventricular injection of 500 ng IFN-γ resulted in significant decreases in the social index and social novelty recognition index (exact numeric values not reported in the abstract). IFN-γ induced hippocampal microglial priming, manifested by enlarged somas, shortened branches, elevated expression of CD68, CD86, CD74, CD11b, CD11c, CD47, IL-33, IL-1β, IL-6, and iNOS, and reduced MCR1, Arg-1, IGF-1, and BDNF. IFN-γ promoted STAT1 phosphorylation and nuclear translocation in microglia. Both minocycline and fludarabine blocked microglial priming, reduced aberrant synapse pruning and microglia-neuron dysfunction, and reversed social memory deficits.
Why it matters
This study defines a specific neuroimmune mechanism linking elevated central IFN-γ to hippocampal microglial priming and social memory impairment via STAT1 activation, highlighting a potential mechanistic target for inflammation-associated social deficits.
Limits
The study was conducted exclusively in male mice and in vitro models, limiting generalizability to female biology and human neurobiology. The abstract provides no specific sample sizes, effect sizes, confidence intervals, or p-values, and does not report long-term functional or behavioral outcomes.